Phenotypic Detection and Polymerase Chain Reaction Screening of Extended-spectrum β-lactamases Produced by Pseudomonas Aeruginosa Isolates
Overview
Microbiology
Affiliations
Background/purpose: A growing number of β-lactamases have been reported in Pseudomonas aeruginosa isolates. The aims of this study were to survey the types of extended-spectrum β-lactamases (ESBLs) by polymerase chain reaction (PCR), to evaluate the reliability of phenotypic tests for ESBLs, and to identify the clonal distribution by pulsed-field gel electrophoresis (PFGE) among P. aeruginosa isolates resistant to expanded-spectrum cephalosporins (ceftazidime, aztreonam, or cefepime).
Methods: The antimicrobial susceptibility of 57 P. aeruginosa isolates from blood specimens were examined according to the recommendations of the Clinical Laboratory Standards Institute. ESBL phenotypes were determined by using cloxacillin-containing double disc synergy test (DDST). The existence of 11 β-lactamase genes was detected by PCR.
Results: Of the 57 P. aeruginosa isolates, 35 (61.4%) isolates were PCR-positive for β-lactamase genes. Twelve of 35 isolates were PCR-positive for combination of ampC and ESBL genes, including TEM, GES, SHV, VEB and OXA-I genes. The sensitivity and specificity of cloxacillin-containing DDST (using the criteria of ceftazidime zone diameter increased ≧5 mm) were 84.1% and 54.5%, respectively. Nine clusters were classified among 35 PCR-positive isolates by PFGE. Isolates of clusters B and C were distributed in different wards of this hospital during a period of 3-4 years.
Conclusion: ESBL genes are not uncommon in P. aeruginosa isolates. Cloxacillin-containing DDST can enhance the sensitivity and has a potential role for phenotypic detection of ESBL-producing P. aeruginosa, and PCR is also helpful for the identification of specific β-lactamase genes. These P. aeruginosa isolates were classified into several diverse clones which could continue to spread in the hospital over a long period of time.
Edward E, El Shehawy M, Abouelfetouh A, Aboulmagd E Infection. 2024; 52(6):2399-2414.
PMID: 38824475 PMC: 11621155. DOI: 10.1007/s15010-024-02297-8.
Aglomasa B, Adu-Asiamah C, Opoku Asiedu S, Kini P, Amewu E, Boahen K BMC Microbiol. 2022; 22(1):245.
PMID: 36221074 PMC: 9552459. DOI: 10.1186/s12866-022-02624-9.
Zagar D, Zore A, Godic Torkar K J Appl Microbiol. 2022; 132(6):4517-4530.
PMID: 35267237 PMC: 9314099. DOI: 10.1111/jam.15520.
Farhadi M, Ahanjan M, Goli H, Haghshenas M, Gholami M Ann Clin Microbiol Antimicrob. 2021; 20(1):70.
PMID: 34583687 PMC: 8479884. DOI: 10.1186/s12941-021-00476-1.
Tchakal-Mesbahi A, Metref M, Singh V, Almpani M, Rahme L Burns. 2021; 47(8):1833-1843.
PMID: 33795157 PMC: 8590735. DOI: 10.1016/j.burns.2021.03.005.